WH2E.DE vs. CURE.DE
WH2E.DE (Invesco S&P World Health Care ESG UCITS ETF Acc) and CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) are both Health & Biotech Equities funds - WH2E.DE tracks the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care while CURE.DE tracks the MVIS Global Future Healthcare ESG. Both are passively managed. Over the past 3 years, WH2E.DE returned 3.13%/yr vs -2.48%/yr for CURE.DE. At a 0.48 correlation, their price movements are largely independent. WH2E.DE charges 0.18%/yr vs 0.35%/yr for CURE.DE.
Performance
WH2E.DE vs. CURE.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WH2E.DE achieves a -3.24% return, which is significantly higher than CURE.DE's -5.10% return.
WH2E.DE
- 1D
- 2.76%
- 1M
- 4.70%
- YTD
- -3.24%
- 6M
- -2.41%
- 1Y
- 10.18%
- 3Y*
- 3.13%
- 5Y*
- —
- 10Y*
- —
CURE.DE
- 1D
- 4.01%
- 1M
- 7.19%
- YTD
- -5.10%
- 6M
- -8.94%
- 1Y
- 5.80%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
WH2E.DE vs. CURE.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
WH2E.DE Invesco S&P World Health Care ESG UCITS ETF Acc | -3.24% | 2.78% | 7.94% | 1.68% |
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -7.72% |
Correlation
The correlation between WH2E.DE and CURE.DE is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.56 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Apr 18, 2023 | 0.48 |
The correlation between WH2E.DE and CURE.DE has been stable across timeframes, ranging from 0.48 to 0.56 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WH2E.DE vs. CURE.DE — Risk / Return Rank
WH2E.DE
CURE.DE
WH2E.DE vs. CURE.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE) and VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WH2E.DE | CURE.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.39 | ||
| Sortino ratioReturn per unit of downside risk | +0.58 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.06 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.83 | 0.30 | +0.53 |
| Martin ratioReturn relative to average drawdown | 2.15 | 0.68 | +1.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WH2E.DE | CURE.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.68 | 0.29 | +0.39 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.20 | -0.14 | +0.34 |
Drawdowns
WH2E.DE vs. CURE.DE - Drawdown Comparison
The maximum WH2E.DE drawdown since its inception was -22.19%, smaller than the maximum CURE.DE drawdown of -34.80%. Use the drawdown chart below to compare losses from any high point for WH2E.DE and CURE.DE.
Loading charts...
Drawdown Indicators
| WH2E.DE | CURE.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -22.19% | -34.80% | +12.61% |
Max Drawdown (1Y)Largest decline over 1 year | -12.23% | -19.07% | +6.84% |
Max Drawdown (3Y)Largest decline over 3 years | -22.19% | -29.32% | +7.13% |
Current DrawdownCurrent decline from peak | -10.45% | -15.66% | +5.21% |
Average DrawdownAverage peak-to-trough decline | -6.94% | -15.12% | +8.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.73% | 8.53% | -3.80% |
Volatility
WH2E.DE vs. CURE.DE - Volatility Comparison
The current volatility for Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE) is 5.21%, while VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a volatility of 5.73%. This indicates that WH2E.DE experiences smaller price fluctuations and is considered to be less risky than CURE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WH2E.DE | CURE.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.21% | 5.73% | -0.52% |
Volatility (6M)Calculated over the trailing 6-month period | 10.46% | 15.20% | -4.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.86% | 19.97% | -5.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.91% | 20.74% | -6.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.91% | 20.74% | -6.83% |
WH2E.DE vs. CURE.DE - Expense Ratio Comparison
WH2E.DE has a 0.18% expense ratio, which is lower than CURE.DE's 0.35% expense ratio.
Dividends
WH2E.DE vs. CURE.DE - Dividend Comparison
Neither WH2E.DE nor CURE.DE has paid dividends to shareholders.
Frequently Asked Questions
WH2E.DE and CURE.DE have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WH2E.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WH2E.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for CURE.DE.
WH2E.DE tracks S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care, while CURE.DE tracks MVIS Global Future Healthcare ESG. They also come from different issuers: Invesco and VanEck. Their fees differ too: 0.18% for WH2E.DE and 0.35% for CURE.DE.
Find the right allocation for WH2E.DE and CURE.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer